1. Home
  2. LODE vs HURA Comparison

LODE vs HURA Comparison

Compare LODE & HURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Comstock Inc.

LODE

Comstock Inc.

BUY

Current Price

$1.78

Market Cap

161.9M

Sector

Industrials

ML Signal

BUY

Logo TuHURA Biosciences Inc.

HURA

TuHURA Biosciences Inc.

HOLD

Current Price

$1.99

Market Cap

160.5M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
LODE
HURA
Founded
1999
2009
Country
United States
United States
Employees
N/A
N/A
Industry
Major Chemicals
Sector
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
161.9M
160.5M
IPO Year
2004
2010

Fundamental Metrics

Financial Performance
Metric
LODE
HURA
Price
$1.78
$1.99
Analyst Decision
Buy
Analyst Count
0
4
Target Price
N/A
★ $8.04
AVG Volume (30 Days)
★ 1.5M
230.8K
Earning Date
11-02-2026
11-13-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 63.55
47.93
EPS
N/A
★ N/A
Revenue
★ $1,553,796.00
N/A
Revenue This Year
$303.79
N/A
Revenue Next Year
$410.04
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$1.70
$0.41
52 Week High
$4.98
$3.43

Technical Indicators

Market Signals
Indicator
LODE
HURA
Relative Strength Index (RSI) 24.01 51.28
Support Level N/A $1.83
Resistance Level $3.32 $2.22
Average True Range (ATR) 0.11 0.13
MACD -0.00 0.01
Stochastic Oscillator 12.90 54.61

Price Performance

Historical Comparison
LODE
HURA

About LODE Comstock Inc.

Comstock Inc commercializes technologies that convert underutilized waste and natural resources into clean energy and supporting products, including electrification, metals, and minerals from end-of-life solar panels. Its subsidiary focuses on producing renewable fuels from waste, energy crops, and woody biomass, supported by facilities in Wisconsin, pilot farms, a biorefinery site in Tulsa, and solar panel recycling operations in Nevada. The Company operates through two high-growth segments and a corporate segment, with its activities grouped into Metals, which generates the majority of revenue, Fuels, Mining, Strategic Investments, and Corporate Services.

About HURA TuHURA Biosciences Inc.

TuHURA Biosciences Inc is a phase 3 clinical stage immuno-oncology company with three distinct technologies focused on the development of novel therapeutics designed to overcome primary and acquired resistance to cancer immunotherapies. The company's personalized cancer vaccine candidate, IFx-2.0, is designed to overcome primary resistance to checkpoint inhibitors. The company operates in one reportable segment, which includes all activities related to advancing therapies for cancer treatment.

Share on Social Networks: